Goop, Gwyneth Paltrow’s lifestyle website, has consistently been in financial trouble, according to newly uncovered corporate filings.
In 2011, Goop “incurred a loss of $255,312 (£152,060) and had a net liabilities of $259,969 (£154,834),” according to documents obtained by RadarOnline. In 2012, Goop reported, “a loss of $39,823 (£23,718) and … net liabilities of $298,512 (£177,788).”
Contrary to what the numbers would imply, Goop had managed to make a considerable amount of money in 2012 – $1,892,065. However, the company’s expenses on the newsletter, product costs and Paltrow and former CEO Sebastian Bishop’s $587,653.25 “remuneration” exceeded their gains. In 2012, both Paltrow and Bishop received “loans to directors.” Paltrow’s loan, which was never paid back, amounted to $49,025.
Despite the discouraging filing, Goop remains optimistic that the future will hold a better financial situation for the company. “As the company started product sales in June 2012, the directors are of the opinion that predicted profits will provide sufficient resources to enable the company to continue trading for the foreseeable future,” a passage in the report reads.
The report further stated that Goop remains, “dedicated to informing and positively inspiring its audience," according to a mission statement on the website.
Paltrow has yet to personally comment on Goop’s finances.
– Chelsea Regan
https://youtu.be/PfBGirey4DE Climate protesters heckled billionaire Stephen Schwarzman over his support for Donald Trump’s election campaign as he…
Nicole Scherzinger apologized after being slammed on social media for posting a comment under a "Make…
Supposedly many of Jackman and Foster’s colleagues were aware of the stars' affair but chose…
https://youtu.be/Txf0IXEdd6U Firefighters continued efforts to contain the Jennings Creek wildfire, burning along the New York-New…
Dru went on to reveal her solution to her son's alarming behavior: “Let’s talk about…
He reported that he started chemotherapy just two weeks after learning of his diagnosis, and…